Scientists at Seattle’s Fred Hutchinson Cancer Research Center have identified a mini-protein in scorpion venom that can target joint inflammation in arthritic rats — and they’re hoping it can do… Read More
Blaze Bioscience, a Seattle-based biotech company that’s using a protein borrowed from scorpion venom to make cancerous tumors glow, has passed its first clinical trial with flying colors and is… Read More
Seattle biotech company Blaze Bioscience has raised $5 million in funding as it pursues a pivotal trial for its “Tumor Paint,” a molecule that binds to cancer cells and lights them… Read More